TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 10.74%1.51B | -8.36%2.76B | -15.49%1.37B | -10.33%3.01B | -11.43%1.62B | 9.74%3.36B | 37.12%1.83B | -25.10%3.06B | -39.71%1.33B | -19.91%4.08B |
Operating income | 10.74%1.51B | -8.36%2.76B | -15.49%1.37B | -10.33%3.01B | -11.43%1.62B | 9.74%3.36B | 37.12%1.83B | -25.10%3.06B | -39.71%1.33B | -19.91%4.08B |
Cost of sales | -10.49%-795.55M | 10.15%-1.45B | 16.68%-720.01M | 17.03%-1.61B | 7.78%-864.14M | -24.00%-1.94B | -37.16%-937.05M | 50.41%-1.57B | 47.56%-683.19M | -6.27%-3.16B |
Operating expenses | -10.49%-795.55M | 10.15%-1.45B | 16.68%-720.01M | 17.03%-1.61B | 7.78%-864.14M | -24.00%-1.94B | -37.16%-937.05M | 50.41%-1.57B | 47.56%-683.19M | -6.27%-3.16B |
Gross profit | 11.01%718.9M | -6.31%1.31B | -14.14%647.62M | -1.12%1.4B | -15.27%754.23M | -5.24%1.41B | 37.08%890.18M | 61.59%1.49B | -28.44%649.38M | -56.55%922.59M |
Selling expenses | 7.70%-514.69M | 9.22%-1.1B | 13.46%-557.61M | 21.04%-1.22B | 12.77%-644.35M | -13.62%-1.54B | -21.21%-738.69M | 16.00%-1.35B | 16.89%-609.44M | -9.63%-1.61B |
Administrative expenses | 10.62%-83.83M | 7.64%-194.96M | 19.98%-93.79M | 18.79%-211.09M | 7.38%-117.21M | 9.60%-259.93M | 15.06%-126.56M | 5.45%-287.52M | -3.38%-149M | -16.70%-304.11M |
Impairment and provision | -108.07%-2.72M | -58.97%31.32M | -34.50%33.73M | 277.56%76.32M | 623.14%51.49M | -170.51%-42.98M | -76.02%-9.84M | 96.21%-15.89M | 20.24%-5.59M | -9,239.94%-419.55M |
-Other impairment is provision | -108.07%-2.72M | -58.97%31.32M | -34.50%33.73M | 277.56%76.32M | 623.14%51.49M | -170.51%-42.98M | -76.02%-9.84M | 96.21%-15.89M | 20.24%-5.59M | -9,239.94%-419.55M |
Special items of operating profit | -0.32%6.18M | -28.79%24.78M | 134.84%6.2M | -29.52%34.8M | -86.54%2.64M | -39.82%49.37M | 226.19%19.61M | 235.13%82.04M | -69.85%6.01M | -74.63%24.48M |
Operating profit | 242.61%123.83M | -18.31%66.61M | -22.77%36.14M | 121.45%81.53M | 34.87%46.8M | -346.19%-380.03M | 131.94%34.7M | 93.87%-85.17M | -352.61%-108.64M | -387.04%-1.39B |
Financing income | 7.06%4M | 13.70%7.62M | 10.33%3.74M | 28.18%6.7M | 36.28%3.39M | 10.20%5.23M | 10.20%2.49M | -52.32%4.74M | -66.51%2.26M | -50.21%9.95M |
Financing cost | 2.36%-12.72M | 10.77%-30.19M | 27.90%-13.02M | 36.38%-33.84M | 19.28%-18.06M | 4.06%-53.18M | 14.61%-22.38M | -83.03%-55.43M | -113.60%-26.21M | -201.18%-30.29M |
Share of profit from joint venture company | -96.89%191K | 115.27%3.97M | 1,201.79%6.15M | -1,207.41%-26.01M | -122.87%-558K | -73.71%2.35M | --2.44M | --8.93M | ---- | ---- |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 121.75%1.18M | -64.27%3M |
Earning before tax | 249.34%115.31M | 69.15%48M | 4.55%33.01M | 106.67%28.38M | 83.01%31.57M | -235.33%-425.64M | 113.13%17.25M | 90.98%-126.93M | -510.25%-131.4M | -380.03%-1.41B |
Tax | -349.24%-37.97M | -67.99%-7.32M | 71.56%-8.45M | 93.82%-4.36M | -841.97%-29.72M | -764.17%-70.42M | -222.43%-3.16M | -90.07%10.6M | -66.45%2.58M | 187.02%106.75M |
After-tax profit from continuing operations | 214.97%77.35M | 69.36%40.69M | 1,225.97%24.56M | 104.84%24.02M | -86.86%1.85M | -326.44%-496.06M | 110.94%14.1M | 91.05%-116.33M | -424.42%-128.83M | -442.40%-1.3B |
Earning after tax | 214.97%77.35M | 69.36%40.69M | 1,225.97%24.56M | 104.84%24.02M | -86.86%1.85M | -326.44%-496.06M | 110.94%14.1M | 91.05%-116.33M | -424.42%-128.83M | -442.40%-1.3B |
Minority profit | -221.37%-5.05M | 80.03%-1.8M | 80.99%-1.57M | -334.99%-9M | -713.27%-8.27M | -216.96%-2.07M | -140.31%-1.02M | 189.34%1.77M | -40.55%2.52M | -243.48%-1.98M |
Profit attributable to shareholders | 215.35%82.4M | 28.64%42.48M | 158.12%26.13M | 106.69%33.02M | -33.02%10.12M | -318.30%-493.99M | 111.51%15.11M | 90.90%-118.1M | -470.35%-131.35M | -443.13%-1.3B |
Basic earnings per share | 216.67%0.038 | 28.48%0.0194 | 160.87%0.012 | 106.71%0.0151 | -32.35%0.0046 | -322.74%-0.2249 | 111.54%0.0068 | 90.79%-0.0532 | -475.16%-0.0589 | -436.79%-0.5776 |
Diluted earnings per share | 208.33%0.037 | 28.48%0.0194 | 160.87%0.012 | 106.71%0.0151 | -32.35%0.0046 | -322.74%-0.2249 | 111.54%0.0068 | 90.79%-0.0532 | -475.16%-0.0589 | -436.79%-0.5776 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.